Bronchiectasis & NTM Association Abstracts & Presentations

The following articles and presentations present research derived from the Bronchiectasis and NTM Research Registry.


2025


NYU Symposium

Geyer A, Brunton AE, Choate R, et al. Age, Sex and Microbiology in U.S. Bronchiectasis and NTM Research Registry Participants. Presented at the 2nd North American Bronchiectasis and NTM Symposium, December 1, NY, NY.

Geyer A, Brunton AE, Jakharia K, et.al. Computed Tomography Signs of Chronic Sinusitis and P. aeruginosa infection in Bronchiectasis: U.S. Bronchiectasis and NTM Research Registry Study. Presented at the 2nd North American Bronchiectasis and NTM Symposium, December 1, NY, NY.

Thornton C, Brunton AE, Geyer A, et al. The Impact of Proton Pump Inhibitor (PPI) Use on Exacerbation Rates in Patients with Bronchiectasis: An Analysis of the US Bronchiectasis and NTM Research Registry. Presented at the 2nd North American Bronchiectasis and NTM Symposium, December 1, NY, NY.

CHEST

Yi DS, Brunton AE, Naureckas ET, et. al. The Impact of Body Mass Index in Bronchiectasis and Non-Tuberculous Mycobacterium (NTM): Findings From the US Bronchiectasis and NTM Research Registry (US BRR). Presented at CHEST, October 19-22, Chicago, IL.

ERS

Choate R, Brunton AE, Aksamit T, et. al. Exploring the Overlapping Burden of Alpha-1 Antitrypsin Deficiency and Bronchiectasis: Insights from the US BRR

Engin L, Cabrera C, Hughes R, et.al. Assessing Exacerbation History and Bronchiectasis Management in the US Bronchiectasis and NTM Research Registry (BRR)

WBC

Thornton C, Brunton AE, Geyer A, et al. The Impact of Proton Pump Inhibitor (PPI) Use on Exacerbation Rates in Patients with Bronchiectasis: An Analysis of the US Bronchiectasis and NTM Research Registry. Presented at the World Bronchiectasis Conference, July 14-17, 2025, Brisbane, Australia.

Feir C, Brunton AE, Choate R, et al. High frequency chest wall oscillation (HFCWO) data in the Bronchiectasis and Nontuberculous Mycobacteria (NTM) Research Registry (BRR). Presented at the World Bronchiectasis Conference, July 14-17, 2025, Brisbane, Australia.

Henkle E, Brunton AE, Engin L, et al. Treatment patterns by exacerbation history in adults with bronchiectasis: data from the U.S. Bronchiectasis and NTM Research Registry. Presented at the World Bronchiectasis Conference, July 14-17, 2025, Brisbane, Australia.

Feltzer J, McShane PJ, Zha BS, et. al. Sociodemographic Factors Associated with Health Outcomes in a Sample of the U.S. Bronchiectasis and Nontuberculous Mycobacteria Research Registry. Presented at the World Bronchiectasis Conference, July 14-17, 2025, Brisbane, Australia.

ATS

Hughes R, Reid F, et. al. Characteristics of Infrequent or Frequent Exacerbators: Data from the Bronchiectasis Research Registry

Swenson C, Marmor M, Solomon GM, et. al. Inhaled Anticholinergics in Bronchiectasis: Prescribing Practices, Exacerbations, and Culture Data from the US Bronchiectasis and Nontuberculous Mycobacterium Research Registry

Poore T, Brunton AE, McShane PJ, et. al. Aspergillus SP. Positive Airway Samples in People with Non-CF Bronchiectasis Is Associated with Higher Biomarkers of Systemic TH2 Inflammation, Allergic Airway Disease, and Airway Co-infection

Grabauskas T, Brunton AE, Metersky ML, et. al. Association of Otitis and/or Rhinosinusitis and Pseudomonas Aeruginosa in Sputum of Patients with Non-cystic Fibrosis Bronchiectasis

Lenhan B, Ignatius E, Marmor M, et. al. Mycobacterium Xenopi: A Small Case Series of Patients in the Bronchiectasis Research Registry

Yohannes AM, Brunton A, Choate R, et. al. Baseline Dyspnea Associated with Risk for Severe Features of Bronchiectasis Phenotype in the US Bronchiectasis and Nontuberculous Mycobacterium Research Registry


2024


ERS

Choate R, McShane PJ, Marmor M, et. al. Multimorbidity in patients with bronchiectasis: results from the US Bronchiectasis and NTM Research Registry (US BRR)

McShane PJ, Locantore N, Choate R, et. al. Clinical features of bronchiectasis according to age in the US Bronchiectasis Research Registry

WBC

Choate R, Marmor M, Jakharia K, et.al. Characteristics Associated with Multimorbidity in Patients with Bronchiectasis: Results from the US Bronchiectasis and NTM Research Registry. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.

Maselli DJ, Brunton AE, Choate R, et.al. The association of the eosinophilic bronchiectasis phenotype and non-tuberculous mycobacterial pulmonary disease: an analysis of the US Bronchiectasis and NTM Research Registry. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.

Maselli DJ, Brunton AE, Choate R, et.al. The eosinophilic bronchiectasis phenotype: findings from the US Bronchiectasis and NTM Research Registry. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.

Marmor M, Mirza A, Brunton AE, et.al. Insights into the Relationship Between Bronchiectasis Exacerbation and Rate of Decline in Spirometry: An Examination of a National Prospective. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.

Mirza A, Marmor M, Brunton AE, et.al. Spirometry trends in bronchiectasis: a detailed examination of pulmonary function patterns from the US bronchiectasis and NTM research registry. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.

Swenson C, Brunton AE, Jakharia K, et.al. Fractional excretion of nitric oxide measurements and respiratory symptom profile among patients with non-CF bronchiectasis – data from the U.S. Bronchiectasis and NTM Research Registry. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.

Zha BS, Ieong M, Brunton AE, et.al. Nontuberculous Mycobacteria Isolation: Impact of Inhaled Mucolytic Therapy in Patients with Bronchiectasis. Presented at the 7th World Bronchiectasis Conference, July 4-6, Dundee, Scottland.

ATS

Prieto M, Brunton AE, Swenson C, et.al. Comparison of the Clinical Features of Bronchiectasis Patients with and Without a History of Tobacco Use - Data from the National Bronchiectasis and NTM Research Registry Consortium

Felzer JR, Chalmers S, Brunton AE, et. al. US Bronchiectasis and NTM Research Registry: Pseudomonas Treatment Patterns in Non-Cystic Fibrosis Bronchiectasis by Sociodemographic Factors

Marmor M, Brunton AE, Fraulino D, et.al. Association Between Nontuberculous Mycobacteria Isolation and Antibiotic Exposure

Vijaykumar K, Brunton AE, Chalmers S, et. al. Clinical Characterization of Patients With COPD- Bronchiectasis Overlap: Data From the US Bronchiectasis and NTM Research Registry


2023


WBC

McShane PJ, Brunton AE, Choate R, et. al. Prevalence and Factors Associated with the Isolation of Fungi in the Sputum of Bronchiectasis Patients

Marmor M, Brunton, AE, Choate, R et. al. Airway Pathogen Trends: A Look at the US Bronchiectasis Research Registry

Aksamit TR, Metersky ML, Locantore N, et. al. Bronchiectasis and NTM Research Registry: 5-year Mortality by BSI and FACED Severity Categories

Chalmers S, Felzer J, Brunton AE, et. al. Pseudomonas Treatment Practice Patterns and Outcomes in Non-Cystic Fibrosis Bronchiectasis: Analysis from the US Bronchiectasis and NTM Research Registry

ATS

Aksamit TR, Lapinel NC, Choate R, et.al. Association of Baseline and Subsequent Bronchiectasis Exacerbations in Patients From the US Bronchiectasis and NTM Research Registry (BRR)

Basavaraj A, Brunton AE, Choate R, et.al. Hypertonic Saline Use in Patients with Bronchiectasis: Analysis from the United States Bronchiectasis and NTM Research Registry

Lapinel N, Aksamit TR, Choate R, et.al. Longitudinal Changes in Forced Expiratory Volume 1 (FEV1) According to Exacerbation Frequency in Patients From the US Bronchiectasis and NTM Research Registry (BRR)

Maselli DJ, Brunton AE, Choate R, et.al. Clinical Features of Patients With an Eosinophilic Phenotype: An Analysis of the U.S Bronchiectasis and NTM Research Registry

McShane PJ, Swenson C, Richards C, et. al. Characteristics of Bronchiectasis Patients Who Tested Positive for Coronavirus Disease 2019 - Data From the United States Bronchiectasis and Nontuberculous Mycobacterial Pulmonary Disease Research Registry

Richards C, Brunton AE, Choate R, et.al. CFTR Mutation and Increased Rates of Pulmonary Infections Among Patients From the US Bronchiectasis and NTM Research Registry

Sullivan L, Brunton AE, Choate R, et.al. Clinical Features of Bronchiectasis Patients With Rheumatoid Arthritis: An Analysis of the Bronchiectasis Research Registry


2022


CHEST

McShane PJ, Choate R, Lapinel, N, et. al. Clinical and microbiologic features in bronchiectasis patients with autoimmunity in the US Bronchiectasis and NTM Research Registry

Shah T, Metersky M, Brunton AE, et, al. Pseudomonas acquisition & long-term macrolide use in patients from the US Bronchiectasis and NTM Research Registry

ERS

Lapinel N, Choate R, Aksamit TR, et. al. Characteristics of frequent exacerbators in the US Bronchiectasis and NTM Research Registry

Aksamit TR, Lapinel N, Choate R, et. al. Longitudinal analysis of bronchiectasis exacerbations (BEx) in patients from the US Bronchiectasis and NTM Research Registry

Drysdale M, Choate R, Lininger N, et. al. Epidemiology of non-tuberculous mycobacterial (NTM) infections in bronchiectasis patients using the US Bronchiectasis/NTM Research Registry

ATS

Kang CJ, Choate R, Metersky ML, et.al. Bronchiectasis and Gender: Results from the National Bronchiectasis and NTM Research Registry

Lapinel N, Choate R, Aksamit TR, et.al. Gastroesophageal Reflux Disease (GERD) and Pulmonary Exacerbation Frequency in Bronchiectasis Patients from the Bronchiectasis and NTM Research Registry (BRR)

Lapinel N, Choate R, Aksamit TR, et.al. Nontuberculous Mycobacteria (NTM) Isolation Status Relative to Pulmonary Exacerbation Frequency in Bronchiectasis Patients: Results from the Bronchiectasis and NTM Research Registry (BRR)


2021


CHEST

Aksamit TR, Choate R, Mannino D, et.al. Descriptive Analysis from the United States Bronchiectasis and NTM Research Registry

ATS

Choate R, Metersky ML, Johnson MM, et al. Racial, Ethnic, and Socioeconomic Disparities in Treatment and Outcomes of Patients with Bronchiectasis and Nontuberculous Mycobacteria (NTM)


2020


ATS

Ku JH, Henkle E, Metersky ML, et al. Pulmonary Nontuberculous Mycobacterial Infection in Patients in the U.S. Bronchiectasis Research Registry: Use of Antibiotic Therapy and Adverse Events

Choate R, Aksamit TR, Addrizzo-Harris DJ, et al. Comparing Clinical Characteristics and Outcomes in Patients with Non-Cystic Fibrosis Bronchiectasis with Non-Tuberculous Mycobacteria and/or Pseudomonas Aeruginosa Within the US Bronchiectasis and NTM Research Registry

Metersky ML, Choate R, Addrizzo-Harris DJ, et al. The Association of Chronic Macrolide Treatment and Incident Isolation of Non-Tuberculous Mycobacteria in Patients with Bronchiectasis


2019


ATS

Ku JH, Chan B, Aksamit TR, et. al. The Validity of Claims-Based Codes to Identify Pseudomonas Infection in Patients with Bronchiectasis in Medicare Data

Choate R, Aksamit TR, Mannino DM, et. al. Pseudomonas Aeruginosa Associated with Severity of Non-Cystic Fibrosis Bronchiectasis Measured by the Modified Bronchiectasis Severity Score (BSI) and the FACED: The US Bronchiectasis and NTM Research Registry (BRR) Study

Basavaraj A, Choate R, Addrizzo-Harris DJ, et. al. Airway Clearance in Non-Cystic Fibrosis Bronchiectasis: Analysis from the United States Bronchiectasis Research Registry


2018


WBC

Aksamit TR, Brunton AE, Siegel, SA, et. al. Colonization with Pseudomonas Aeruginosa as a Predictor of Future Nontuberculous Mycobacteria Isolation

Metersky ML, Choate R. The Association of Stenotrophomonas Maltophilia with Patient Characteristics and Outcomes in Bronchiectasis

DiMango A, Choate R. Aspergillus Airway Colonization in Non-CF Bronchiectasis Patients is not Associated with Disease Severity

Despotes KA, Choate R, Daniels MLA, et.al. Markers of Non-Cystic Fibrosis Bronchiectasis Disease Severity and Nutrition in the United States Bronchiectasis Research Registry

Choate R, Mannino DM, Aksamit T. et al. Pseudomonas Aeruginosa Impact on Severity of Bronchiectasis

ATS

Choate R, Eden E, Addrizzo-Harris DJ, et. al. The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency, and Primary Ciliary Dyskinesia


2017


WBC

Pravosud V, Mannino DM, Choate R, et. al. Medication use as a measure of severity: Findings from the COPD Foundation NTM Social Survey

Pravosud V, Mannino DM, Choate R, et. al. Symptom burden among patients reporting nontuberculous mycobacteria (NTM): Findings from the COPD Foundation Survey

Choate R, Mannino DM, Aksamit T, et. al. Pseudomonas Aeruginosa Impact on Severity of Bronchiectasis

ATS

Aksamit TR, Choate R, O'Donnell AE, et. al. United States Bronchiectasis Registry Longitudinal Follow Up at Two Years


2015


ATS

Henkle E, Daley CL, Griffith DE, et. al. Patterns of Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis


2013


ATS

Winthrop KL, Aksamit T, Olivier K, et. al. The Respiratory Microbiology of Patients with Nontuberculous Mycobacteria from the United States Bronchiectasis Research Registry

Metersky M, O’Donnell A, Daley C, et. al. Staphylococcus aureus in Patients with non-CF Bronchiectasis: Results from the Bronchiectasis Research Registry


2012


ATS

Aksamit TR, Carretta E, Daley CL, et. al. The Bronchiectasis Research Registry: A Collaborative Research Cohort For Non-Cystic Fibrosis Bronchiectasis


2011


ATS

Czaja CA, Stewar D, Levin A, et. al. Prevalence and Clinical Significance of Mucoid Pseudomonas Aeruginosa Infection in Adults with Non-Cystic Fibrosis Bronchiectasis - Results From The Bronchiectasis Research Registry

Stewart D, LaVange L, Thomashow B, et. al. The Added Perspective of Changes Over Time, A Resource for Collaborative Research in Non-Cystic Fibrosis Bronchiectasis


2010


ATS

LaVange L, Stewart D, Thomashow B, et. al. The Bronchiectasis Research Registry: a Resource for Collaborative Research in non-Cystic Fibrosis Bronchiectasis

O'Connell ML, Prevots DR, Olivier KN, et. al. The Bronchiectasis Research Registry: Clinical, Microbiologic, and Treatment Characteristics